Helen Joseph Hospital
Johannesburg, Gauteng, South Africa
Location status: Recruiting
NCT Number: NCT07428577
Despite the scale-up of HIV testing and the implementation of the universal test-and-treat policy, a substantial proportion of people living with HIV (PLHIV) continue to present with advanced HIV disease (AHD), defined by a CD4 count below 200 cells/µL and/or WHO clinical staging of stage 3 or 4. Global and regional analyses estimate that nearly half of hospitalized PLHIV meet criteria for AHD, with similar findings reported in South Africa. Patients with AHD face high risks of opportunistic infections, hospitalization, and mortality, and frequently disengage from care after discharge. This study aims to examine inpatient and post-discharge care pathways for individuals with AHD in South Africa, identify gaps in continuity of care between hospitals and primary healthcare (PHC) facilities, and generate evidence to inform strategies that strengthen linkage, retention, and long-term outcomes.
A prospective cohort study with a nested process evaluation will be conducted at Helen Joseph Hospital, a large public tertiary facility in Johannesburg. Adult patients (≥18 years) admitted with HIV-related conditions and meeting AHD criteria will be consecutively enrolled once deemed clinically stable. Data will be collected through structured inpatient interviews, medical-record reviews, and follow-up telephone interviews at four- and eight-weeks post-discharge to assess linkage to PHC services, ART continuation, and readmissions. Quantitative data will be analyzed descriptively using standard statistical methods.
This study will generate a detailed understanding of how patients with AHD transition from inpatient to outpatient HIV care, highlighting critical points where continuity of care fails. Findings will identify system- and patient-level barriers to effective linkage and retention and inform interventions to improve post-discharge outcomes. The study poses minimal risk to participants, involving only structured interviews and review of existing medical records, with no invasive procedures.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Johannesburg, Gauteng, South Africa
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 weeks after hospital discharge
Self-reported proportion of discharged patients who successfully return to PHC facilities and start, resume, or continue ART.
Time frame: 8 weeks after hospital discharge
Completeness and quality of discharge documentation, including referrals to PHC and follow-up instructions
Contact information is provided by the study sponsor or research team.
Elizabeth Kachingwe
CONTACT
27 61 066 3132
Linda Sande
CONTACT
Boston University
Other
Acronym: TRACK-AHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06904456
Advanced HIV Disease
Lusaka, Zambia
View Trial DetailsNCT07720128
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Lusaka, Zambia
View Trial DetailsNCT06852430
Acquired Immunodeficiency Syndrome, Advanced HIV Disease
View Trial Details